Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE Trial
ArticleAbstract: Background: Translating evidence into clinical practice in the management of acute ischemic stroke (Palabras claves:Autores:Bahit C., Berwanger O., Bettger J.P., Bueno P.R.T., Cavalcanti A.B., da Silva B.G.P., Damiani L.P., De Andrade Jesuíno I., De Salles A., Freitas G.R.d., Gorgulho A., Guimarães H.P., Lopes R.D., Machline-Carrion M.J., Málaga G., Martins S.O., Normilio-Silva K., Octavio Marques Pontes-Neto, Peterson E.D., Santos J.Y., Santucci E.V., Xian Y., Zétola V.H.F.Fuentes:scopusEffect of a Quality Improvement Intervention on Adherence to Therapies for Patients with Acute Ischemic Stroke and Transient Ischemic Attack: A Cluster Randomized Clinical Trial
ArticleAbstract: Importance: Translating evidence into clinical practice in the management of acute ischemic stroke (Palabras claves:Autores:Bahit M.C., Berwanger O., Bettger J.P., Bueno P.R.T., Cavalcanti A.B., Damiani L.P., De Andrade Jesuíno I., De Salles A., Gorgulho A., Guimarães H.P., Lopes R.D., Machline-Carrion M.J., Málaga G., Martins S.O., Normilio-Silva K., Octavio Marques Pontes-Neto, Pacheco Da Silva B.G., Peterson E.D., Rodrigues De Freitas G., Santos J.Y., Santucci E.V., Xian Y., Zétola V.H.F.Fuentes:scopusEffects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial
ArticleAbstract: Background: Trials of β blockers in patients undergoing non-cardiac surgery have reported conflictinPalabras claves:Autores:Aggarwala R., Alonso-Coello P., Argibay-Poliquin E., Avezum A.J., Badner N., Baer C., Baidel Y., Baptista M., Barratt S., Beattie W.S., Bednarowski M., Beilby D., Bertozzi H.A., Berwanger O., Blacher C., Bodanese L.C., Boisvenu G., Bolsin S., Boulton A., Boyd D., Brunet D., Bryson G.L., Bugler S., Burlingham J., Caccavo R.A., Campeau J., Campos De Albuquerque D., Carlos Zevallos J., Chan M.T.V., Choi P., Chrolavicius S., Ciapponi A., Cope L., Devereaux P.J., Do Amara Baruzzi A.C., Douglas J., Esteves J.P., Faller J., Fatovich S., Ferrari A., Foëx P., França Neto O.R., Gannedahl P., Garcia Dieguez M., Giles J., Goldman L., Grant J., Greenspan L., Guiselli Gallina L.E., Guyatt G.H., Halliwell R., Hudson R.J., Islas Andrade S., Izukawa N.M., Jacka M.J., Kallas F.C., Keltai M., Kerr Saraiva J.F., Kerridge R.K., Leino K., Leslie K., Liu L., Love J., Málaga G., March S., Marin-Neto J.A., Mauricio Espinel, McCulloch T.J., Montori V.M., Myles P.S., Nicolosi L.N., Nigro Maia L., Paech M., Pais P., Penha Rosateli P.H., Peyton P., Phrommintikul A., Pogue J., Poole C., Poustie S., Priestly M., Rabello R., Raeder J., Reeves M., Salazar A., Schammass Ducatti T., Schricker T., Sear J., Sierra F., Tesolin P., Tristan M., Urŕutia G., Wallace S., Warriner B., Weitkamp B., Wolfers D., Xavier D., Xu S., Yang H., Yusuf S.Fuentes:scopusThe Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges
ArticleAbstract: Background: Effective treatments for COVID-19 are urgently needed, but conducting randomized trialsPalabras claves:Autores:Anand S.S., Avezum A.J., Bangdiwala S.I., Belley-Cote E.P., Beresh H., Berwanger O., Bosch J.J., Chan N., Choudhri S., Dans A.L., DIaz R., Eikelboom J.W., Farkouh M.E., Felix Camilo, Harper W.L., Hassany M., Jolly S.S., Kazmi K., Kontsevaya A., Lewis G., Loeb M., Lopes R.D., Nkeshimana M., Orlandini A., Pais P., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Sharma S.K., Tarhuni W.M., Wasserman S., Whitlock R.P., Xavier D., Xu L., Yusuf S., Yusufali A.M.Fuentes:googlescopus